Crinetics Pharmaceuticals
CRNX
Last Price
52 Week Range
$24.10 - $57.99
Next Earnings Date
May 14 2026 (Estimate)
Next Earnings Date
May 14 2026 (Est.)
Last Price
Crinetics Pharmaceuticals SEC Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Crinetics Pharmaceuticals, Inc. | 8-K | March 23, 2026 | |
Crinetics Pharmaceuticals, Inc. | 8-K | March 3, 2026 | |
Crinetics Pharmaceuticals, Inc. | 8-K | February 26, 2026 | |
Crinetics Pharmaceuticals, Inc. | 10-K | February 26, 2026 | |
Crinetics Pharmaceuticals, Inc. | 8-K | January 26, 2026 | |
Crinetics Pharmaceuticals, Inc. | 8-K | January 13, 2026 | |
Crinetics Pharmaceuticals, Inc. | 8-K | January 7, 2026 | |
Crinetics Pharmaceuticals, Inc. | 8-K | January 5, 2026 | |
Crinetics Pharmaceuticals, Inc. | 8-K | December 17, 2025 | |
Crinetics Pharmaceuticals, Inc. | 10-Q | November 6, 2025 | |
Crinetics Pharmaceuticals, Inc. | 8-K | November 6, 2025 | |
Crinetics Pharmaceuticals, Inc. | 8-K | September 26, 2025 | |
Crinetics Pharmaceuticals, Inc. | 10-Q | August 7, 2025 | |
Crinetics Pharmaceuticals, Inc. | 8-K | August 7, 2025 | |
Crinetics Pharmaceuticals, Inc. | 8-K | June 30, 2025 | |
Crinetics Pharmaceuticals, Inc. | 8-K | June 26, 2025 | |
Crinetics Pharmaceuticals, Inc. | 8-K | June 12, 2025 | |
Crinetics Pharmaceuticals, Inc. | DEFA14A | May 20, 2025 | |
Crinetics Pharmaceuticals, Inc. | 10-Q | May 8, 2025 | |
Crinetics Pharmaceuticals, Inc. | 8-K | May 8, 2025 | |
Crinetics Pharmaceuticals, Inc. | DEF 14A | April 23, 2025 | |
Crinetics Pharmaceuticals, Inc. | DEFA14A | April 23, 2025 | |
Crinetics Pharmaceuticals, Inc. | ARS | April 23, 2025 | |
Crinetics Pharmaceuticals, Inc. | 8-K | April 4, 2025 | |
Crinetics Pharmaceuticals, Inc. | 8-K | February 27, 2025 | |
Crinetics Pharmaceuticals, Inc. | 10-K | February 27, 2025 | |
Crinetics Pharmaceuticals, Inc. | 8-K | February 24, 2025 | |
Crinetics Pharmaceuticals, Inc. | 8-K | January 14, 2025 | |
Crinetics Pharmaceuticals, Inc. | 8-K | January 10, 2025 | |
Crinetics Pharmaceuticals, Inc. | 8-K | December 16, 2024 |
Load More...
Gainify
Features
Platform
Resources
Learn
Socials
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
© 2026 Gainify. All rights reserved.